Martina Kovarova Archives | Institute for Global Health and Infectious Diseases

Skip to main content

IGHID Investigators Participate in CROI Conference

Investigators with the Institute for Global Health and Infectious Diseases (IGHID) participated in the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, California, March 9-12. Following are some highlights. In a CROI preview, Joe Eron, MD, was interviewed for the “Going Anti-Viral” IAS-USA podcast, discussing the...

Kovarova Receives Grant to Develop Long-Acting Tuberculosis Treatment Option for Low- and Middle-Income Countries

October 15, 2024

Martina Kovarova, PhD, a member of the Institute for Global Health and Infectious Diseases, and associate professor of infectious diseases, has received a grant from the Bill & Melinda Gates Foundation to develop new Tuberculosis treatment options using ISFI (in-situ forming implant) technology. The TB Alliance, the global not-for-profit developer...

Penile HIV Infection is Effectively Prevented by Antiretroviral Treatment

Researchers at the UNC School of Medicine’s International Center for the Advancement of Translational Science and the Institute for Global Health and Infectious Diseases have developed a new approach for the detailed evaluation of HIV infection throughout the entire male genital tract, HIV acquisition via the penis and the efficient...

Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in...